Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity

Human low-density lipoprotein (LDL) was glucosylated by incubation in vitro with glucose (20–80 mM) with or without addition of cyanoborohydride. The incorporation of covalently bound glucose was linear over time, and amino acid analysis showed the presence of glucosyllysine residues. The glucosylated LDL (glc LDL) moved more rapidly than normal LDL on agarose electrophoresis. The rate of degradation of 125I-labeled glucosylated LDL (glc LDL) by cultured human fibroblasts was reduced compared with that of native 125I-LDL, the difference increasing with extent of glucosylation. Effects were seen with blockage of as few as 6–15﹪ of the LDL lysine residues; high-affinity degradation was completely lost when one-third of the lysine residues were blocked. Conjugation of LDL with glucose-6-phosphate also blocked high-affinity uptake and degradation. Whereas native LDL uptake inhibited the activity of β-hydroxy-β-methylglutaryl coenzyme A reductase and stimulated acyl coenzyme A:cholesterol acyltransferase activity, glc LDL had no effects on these enzymes. The fractional catabolic rate of glc LDL in guinea pigs was reduced. Degradation of glc LDL by mouse peritoneal macrophages was not significantly faster than that of native LDL. Finally, the presence of glc LDL in human plasma was demonstrated. Preliminary data show that 1.3﹪ of lysine residues in normal LDL and 2–5.3﹪ of lysines in diabetic LDL were glucosylated. Since, like other plasma proteins, LDL undergoes glucosylation in diabetes, its turnover and sites of catabolism may differ from normal and this may be relevant to the accelerated atherosclerosis of diabetes.

[1]  V. J. Stevens,et al.  Diabetic cataract formation: potential role of glycosylation of lens crystallins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Gallop,et al.  The glycosylation of hemoglobin: relevance to diabetes mellitus. , 1978, Science.

[3]  E. Schleicher,et al.  Non‐enzymatic glycosylation of human serum lipoproteins Elevated ϵ‐lysine glycosylated low density lipoprotein in diabetic patients , 1981, FEBS letters.

[4]  A. Cerami,et al.  Measurement of Glycosylated Amino Acids and Peptides from Urine of Diabetic Patients Using Affinity Chromatography , 1980, Diabetes.

[5]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Bailey,et al.  Age-related changes in collagen: the identification of reducible lysine-carbohydrate condensation products. , 1972, Biochemical and biophysical research communications.

[7]  P. Edwards,et al.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[8]  O. Wieland,et al.  Increased Glycosylation of Serum Albumin in Diabetes Mellitus , 1980, Diabetes.

[9]  D K Yue,et al.  Glycosylation of Plasma Protein and its Relation to Glycosylated Hemoglobin in Diabetes , 1980, Diabetes.

[10]  P. Gallop,et al.  Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. , 1975, Biochemical and biophysical research communications.

[11]  Z. Cohn,et al.  Response of endocytosis to altered fatty acyl composition of macrophage phospholipids. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Baynes,et al.  Nonenzymatic Glucosylation of Serum Proteins and Hemoglobin: Response to Changes in Blood Glucose Levels in Diabetic Rats , 1980, Diabetes.

[13]  A. Bailey.  The nonenzymatic glycosylation of proteins. , 1981, Hormone and metabolic research. Supplement series.

[14]  R. Mahley,et al.  Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. , 1979, The Journal of clinical investigation.

[15]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[16]  M. Bitensky,et al.  Micropinocytic ingestion of glycosylated albumin by isolated microvessels: possible role in pathogenesis of diabetic microangiopathy. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Carew,et al.  Turnover and tissue distribution of 125-I-labeled low density lipoprotein in swine and dogs. , 1975, Journal of lipid research.

[18]  R. Mahley,et al.  Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Gravallese,et al.  Nonenzymatic Glycosylation of Erythrocyte Membrane Proteins , 1980 .

[20]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[21]  G. Schonfeld,et al.  Nonenzymatic Glycosylation of Low Density Lipoproteins In Vitro: Effects on Cell-interactive Properties , 1981, Diabetes.

[22]  T. Carew,et al.  Enhanced degradation of trypsin-treated low density lipoprotein by fibroblasts from a patient with homozygous familial hypercholesterolemia. , 1978, Biochimica et biophysica acta.

[23]  F. Hatch.  Practical methods for plasma lipoprotein analysis. , 1968, Advances in lipid research.

[24]  C. Drevon,et al.  Metabolism of homologous and heterologous lipoproteins by cultured rat and human skin fibroblasts. , 1981, Journal of lipid research.

[25]  G. Camejo,et al.  The affinity of low density lipoproteins for an arterial macromolecular complex. A study in ischemic heart disease and controls. , 1976, Atherosclerosis.